Lancet (London, England) LANCET RECOVERY Collaborative Group 2021, ' Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY) a randomised controlled, open-label, platform trial ', The Lancet, vol. 397, no. 10289, pp. 2049-2059 . https://doi.org/10.1016/S0140-6736(21)00897-7 Mumford, A D 2021, ' Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised controlled, open-label, platform trial ', Lancet, vol. 397, no. 10289, pp. 2049-2059 . https://doi.org/10.1016/S0140-6736(21)00897-7 Group, RECOVERY C & Dark, P 2021, ' Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. ', Lancet (London, England), vol. 397, no. 10289, pp. 2049-2059 . https://doi.org/10.1016/S0140-6736(21)00897-7
Hicks, D, Rafiee, G, Schwalbe, E C, Howell, C I, Lindsey, J C, Hill, R M, Smith, A, Adidharma, P, Steel, C, Richardson, S, Pease, L, Danilenko, M, Crosier, S, Joshi, A, Wharton, S, Jacques, T, Pizer, B, Michalski, A, Williamson, D, Bailey, S & Clifford, S C 2020, ' The molecular landscape and associated clinical experience in infant medulloblastoma prognostic significance of second-generation subtypes ', Neuropathology and Applied Neurobiology . https://doi.org/10.1111/nan.12656